Michael D Pruitt
CIK 1124144 · Chief Executive Officer · last filed 2026-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.9K
Companies
9
Total Filings
112
Lifetime Open-Market Net
$71.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FWDI | Chief Executive Officer | 1,500 | $4.28 | $6.4K | $9.5K | 3 | 2026-05-19 |
| Forward Industries, Inc. (FORD) Delisted | Chief Executive Officer | — | $9.48 | — | $0 | 2 | 2025-09-11 |
| BACK | Director | 12,141 | $0.04 | $522 | $0 | 1 | 2025-01-02 |
| IMAC Holdings, Inc. (IMACW) Delisted | Director | 8,808 | $0.01 | $106 | $1.2K | 9 | 2023-12-27 |
| AMAZE HOLDINGS, INC. (VINE) Delisted | Director | 30,000 | $0.57 | $17.2K | $0 | 2 | 2023-04-04 |
| Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | CEO, Chairman | 17,596 | — | — | $47.7K | 21 | 2020-03-24 |
| Sonnet BioTherapeutics Holdings, Inc. (HOTR) Delisted | CEO, Chairman | 20,731 | — | — | $811 | 3 | 2017-09-27 |
| Sonnet BioTherapeutics Holdings, Inc. (HOTRW) Delisted | CEO, Chairman | 20,731 | — | — | $12.4K | 23 | 2017-06-15 |
| Sonnet BioTherapeutics Holdings, Inc. (HOTRU) Delisted | Cheif Executive Officer | 203,305 | — | — | $0 | 1 | 2012-07-17 |
Recent Filings · Page 5 of 12
112 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-31 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Buy (P) | +105 | $118 | EDGAR |
| 2019-06-27 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Exer (X) | +500 | $500 | EDGAR |
| 2019-06-20 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Exer (X) | +9,000 | $9.0K | EDGAR |
| 2019-06-04 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Buy (P) | +1,100 | $1.1K | EDGAR |
| 2019-05-29 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Buy (P) | +1,000 | $1.1K | EDGAR |
| 2018-12-31 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Buy (P) | +1,000 | $1.3K | EDGAR |
| 2018-12-17 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Buy (P) | +500 | $1.0K | EDGAR |
| 2018-11-30 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Buy (P) | +500 | $880 | EDGAR |
| 2018-11-28 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Buy (P) | +1,000 | $1.8K | EDGAR |
| 2018-11-16 | Sonnet BioTherapeutics Holdings, Inc. (BURG) Delisted | Buy (P) | +400 | $776 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.